


In Jan 1ST, 2001 GenMont was established by the internationally esteemed clinical/experimental immunologist Dr. Hsu, Ching-shiang, with now a capital of NTD 300 millio around USD 8.8 millio. Currently our proprietary technologies have being patented worldwide and the business has being extended to new drug discovery as well as functional food development. We are now intended to be a market overt into Taiwan stock market in late 2003.
*Executive summary
GenMont is engaged in the developmen... More